Ipec-Plus Tablet

Generic

Iron Polymaltose Complex + Folic Acid + Zinc Sulfate.

 

Indications

This tablet is indicated for the treatment and prevention of Iron, Folic Acid, and Zinc deficiencies.

 

Pharmacology

This tablet is the planning of Press, Folic Corrosive, and Zinc. In this arrangement, Press shows as Press (III) Hydroxide Polymaltose Complex, a respectable Press arrangement. It contains non-ionic Ferric Press and Polymaltose in a steady complex. This complex encourages controlled assimilation of the Press when it comes in contact with the mucosal cell surface. Due to its non-ionic nature, Press (III) Hydroxide Polymaltose Complex is more steady than ordinary Press shape. Folic Corrosive makes a difference in the appropriate improvement of the hatchling. Zinc keeps proteins working and makes a difference to metabolize proteins.

 

Dosage & Administration

One tablet daily. Two tablets may be required a day in severe cases or as directed by the physician.

 

Interaction

Ionic interaction with foodstuff components (phytates, oxalates, tannin, etc.) and concomitant administration of medicaments (tetracyclines, antacids) are unlikely to occur since Iron is complexly bound.

 

Contraindications

This tablet is contraindicated in patients with a known hypersensitivity to any of the ingredients of this product.

 

Side Effect

This tablet is generally well tolerated. However, a few side effects of oral iron preparations, including nausea, vomiting, constipation, or diarrhea may occur rarely.

 

Pregnancy & Lactation

Any medicine should be avoided during the first trimester of pregnancy if at all possible. As a result, administering Iron in the first trimester necessitates conclusive evidence of Iron insufficiency.

 

Precautions & Warnings

As with all Press arrangements, the dull coloration of the stool may happen which is without clinical importance.

 

Therapeutic Class

Preparation with Iron, Vitamins, and Minerals

 

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children.

 

Pharmaceutical Name

Aristopharma Ltd.